Fetal bovine serum, US origin FBS) (ambis #2180219)

Ended Purchase Order Awarded

Contract number
75N93023P00983
Awardee
Awarding agency
Obligated
$19,255

Award facts

Contract value 100% obligated
$19,254.92 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6509 Drugs And Biologicals, Veterinary Use
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Broderick, CA 95605, USA

Award details come from SAM.gov/FPDS.

About this award

Gemini Bioproducts LLC has been awarded a $19,254.92 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide Fetal Bovine Serum (FBS), U.S. origin, as described in NIH requisition number 2180219. Performance will occur in West Sacramento, California over a period of two months concluding in late September 2023. The contract action was funded through the Department of Health and Human Services and supports the NIH's ongoing research efforts into allergy and infectious disease under the NIAID's programs. No set aside designation or subcontractors beyond the prime were identified.

Quick answers

Who was awarded contract 75N93023P00983?

75N93023P00983 was awarded to Gemini Bioproducts LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 21, 2023.

How much is contract 75N93023P00983 worth?

The government has obligated $19,255 on 75N93023P00983.

Was contract 75N93023P00983 competed?

The extent of competition for 75N93023P00983 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award